BackElevation Oncology Overview

Elevation Oncology Other Assets

Elevation Oncology's other assets is $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00
↓ 100.00% YoYΔ $-1.00 vs prior year quarter

Peer trimmed avg / median

Loading

Elevation Oncology Other Assets History

Loading

Elevation Oncology vs. peers: Other Assets Comparison

Loading

Elevation Oncology Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Elevation Oncology (ELEV) FAQ

As of the most recent data (March 2025), ELEV shows a other assets of $0. That compares with $1 in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ELEV's other assets is now $0 (was $1) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Elevation Oncology is outperforming or lagging.

Tracking ELEV's other assets over time shows whether Elevation Oncology is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $1 in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other assets page, Stockcircle has Elevation Oncology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other assets (currently $0) with ownership activity and broader fundamentals.

Elevation Oncology's other assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.